Fri, Dec 19, 2014, 10:53 AM EST - U.S. Markets close in 5 hrs 7 mins

Recent

% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • hokiestock hokiestock Mar 9, 2013 1:08 AM Flag

    Pipeline questions? CD 89 and HIV product

    Are just participating with Rockefeller and do not get any revenue from the AIDS vaccine if it becomes approved? As well has anyone heard what is going with the CD89 Product that antibody has some interesting anti-inflammatory properties. What happen to all the old Avant rolaly partnerships with Glaxo on the vaccines theres. I was just reviewing the mergers Celldex had and I forgot I use to follow everyone of those companies but just let Celldex go through the recession and oncy BMY took out MEDX. Good stuff people you could spend a whole week learning about the possible targets for these products and 250 patents.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • There is probably no direct financial gain for Celldex even if it gets approved. That is years away anyway. However, if phase 1 results are good then the news alone would likely affect Celldex's share price. It would validate their technology further. It would be big news! That could mean companies might seek out Celldex for a viral vaccine partnership. As far as your other questions, I'm not sure about the status. All I know Hokie is that CLDX is a monster as Jooty put it. I can only imagine how many companies are pleading with Celldex for a partnership. I hope Celldex has a good posion pill.

      Sentiment: Strong Buy

 
CLDX
18.8466+0.0266(+0.14%)10:53 AMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.